Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial

Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.1 to v3.7.2. The study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T16:42:47.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error for the study record. The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T17:15:19.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content. This indicates restricted access to the NCT03030612 page and blocks viewing the study details in ClinicalTrials.gov.
    Difference
    19%
    Check dated 2026-09-19T20:17:34.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The study record now includes NIH grant/contract funding information for 2016, and the page revision has been updated to v3.6.6 (replacing the previous v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-29T21:56:15.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a newer version of the page. This update appears to be an internal revision with no substantive changes to the study details displayed.
    Difference
    0.1%
    Check dated 2026-08-08T18:56:07.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, representing a small update to the page's version metadata. There is no indication of substantive changes to the study details or related content.
    Difference
    0.1%
    Check dated 2026-07-25T10:41:58.000Z thumbnail image

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.